Skip to content

Clinical trials

Dyslipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Clear all

1,191 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
20016
20029
200326
200429
200541
200664
200751
200852
200934
201041
201156
201246
201339
201451
201547
201650
201745
201845
201957
202033
202159
202248
202356
202462
202556
202663

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed790
Unknown status144
Recruiting83
Terminated55
Active, not recruiting40
Not yet recruiting39
Withdrawn25
Enrolling by invitation8
Suspended4
No longer available1
Available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca57
Takeda47
Chong Kun Dang Pharmaceutical41
Merck Sharp & Dohme LLC22
Novartis Pharmaceuticals15
Pfizer15
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.15
Daewoong Pharmaceutical Co. LTD.12
Yonsei University12
Abbott11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias1,191
Hypertension277
Diabetes Mellitus198
Obesity196
Diabetes Mellitus, Type 2164
Hypercholesterolemia139
Cardiovascular Diseases131
Metabolic Syndrome115
Hyperlipidemias100
Insulin Resistance76

Trials

Showing 26 to 50 of 1,191. Each trial links to its page on Pharma Observatory.

1,091 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.